Page 2 - Drug Manufacturers

USFDA rush after 2-year lull: 20-30% new products may be open to inspection

The last two years saw limited physical inspections due to travel restrictions during the pandemic

Mandaviya urges bulk drug manufacturers to invest more in research

The chemicals and fertilizers minister, who also holds the health portfolio, praised the industry players for playing a pivotal role during Covid times, not only domestically but also globally

Price erosion in US drags Alembic Pharma's Q3 net down 40% to Rs 176 cr

While the firm's US business fell 23% to Rs 393 cr in Q3FY22, its API sales were down 7% to Rs 198 crore

Wockhardt reports consolidated net profit of Rs 1.77 cr in Q3

Drug maker Wockhardt on Thursday reported a consolidated net profit of Rs 1.77 crore for the third quarter of 2021

Pfizer Ltd net profit rises 9% to Rs 143 crore in September quarter

The drug firm on Wednesday reported an 8.81% rise in net profit

Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr

Drug maker Lupin on Thursday reported an 18 per cent increase in its consolidated net profit at Rs 460 crore for the fourth quarter, driven by robust sales across domestic and international markets

Govt engaging with drug makers to ramp up production of anti-fungal drug

The government is engaging with the drug manufacturers to ramp up the production of an antifungal drug used for the treatment of mucormycosis, says Chemicals and Fertilizers Ministry

J&J, other drugmakers go to trial in US in $50 bn case over opioid abuse

J&J, Teva Pharmaceutical Industries Ltd, Endo International Plc and AbbVie's Allergan unit are alleged of fueling a drug crisis that according to the US government resulted in nearly 500,00 deaths

PE firm Advent International acquires 51% stake in ZCL Chemicals

ZCL is one of the fastest-growing manufacturers of specialty active pharmaceutical ingredients (APIs) and advanced intermediates

Shelf life of vaccines likely to be more than 3 months, unlike drugs

They have the stability data for these investigational products, said a source

Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%

The company's prescription biz grew 14% YoY supported by continued traction in the Covid portfolio

Govt revises PLI scheme for bulk drugs to boost local manufacturing

Industry says revised PLI scheme will attract more MSMEs to invest as minimum investment clause done away with

Revised, more industry-friendly PLI scheme for bulk drugs on the cards

Industry says move will mean lower spends and reduced dependence on China

As domestic sales decline, drug makers focus on exports to sustain growth

During April-July, drug makers exported products worth $ 7.4 billion, a growth of 9.5 per cent on year on year basis

CVS raises profit forecast, in talks with US to administer Covid vaccines

CVS also said it was working with laboratories to cut down the turnaround time for coronavirus test results, which had spiked in July due to a massive increase in demand for tests

Govt notifies incentive scheme for local API manufacturing to cut imports

According to a government notification, bulk drugs accounted for 63 per cent of total pharmaceutical imports in the country in 2018-19.

Cipla to price Covid-19 drug remdesivir at less than Rs 5,000 per vial

Hyderbad-based drug firm Hetero on Sunday said that it will price its generic version of the drug in the range of Rs 5,000-6,000 per dose

Pvt players must help set up bulk drug, med devices pak: Mandaviya

The minister also said India can progress, if health and hygiene are also included in the overall economic development plan

Glenmark Pharma gets nod to launch favipiravir for Covid-19 patients

Glenmark is conducting phase-3 clinical trials; drug has got restricted emergency use

Revised Wockhardt deal boosts prospects of Dr Reddy's India business

The company, according to its new strategy, is focusing on growing its India-based branded products